TCL Archive FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications. May 11, 2007
TCL Archive Phase II Study Meets Primary Endpoint, Demonstrating Overall Survival of 5.2 Months September 27, 2013
TCL Archive Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research November 15, 1996
TCL Archive SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer October 28, 2005
TCL Archive Two-Year Remission While Taking Gleevec Puts Patients Into Normal Mortality Rate March 25, 2011
